Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial

Partelli S;Massironi S;Zerbi A;Niccoli P;Kwon W;Landoni L;Panzuto F;Tomazic A;Bongiovanni A;Kaltsas G;Sauvanet A;Bertani E;Mazzaferro V;Caplin M;Armstrong T;Weickert MO;Ramage J;Segelov E;Butturini G;Staettner S;Cives M;Frilling A;Moulton CA;He J;Boesch F;Selberheer A;Twito O;Castaldi A;De Angelis CG;Gaujoux S;Holzer K;Wilson CH;Almeamar H;Vigia E;Muffatti F;Lucà M;Lania A;Ewald J;Kim H;Salvia R;Rinzivillo M;Smid A;Gardini A;Tsoli M;Hentic O;Colombo S;Citterio D;Toumpanakis C;Ramsey E;Randeva HS;Srirajaskanthan R;Croagh D;Regi P;Gasteiger S;Invernizzi P;Ridolfi C;Giovannini M;Jang JY;Bassi C;Falconi M.

2022-01-01